Congress cuts $23 million from nuclear medicine research
Nuclear medicine scientists expressed dismay about Congressional approval of a federal budget plan that could close the book on a half-century of nuclear medicine research sponsored by the Department of Energy.
Nuclear medicine scientists expressed dismay about Congressional approval of a federal budget plan that could close the book on a half-century of nuclear medicine research sponsored by the Department of Energy.
The budget plan, approved by the House and Senate Nov. 10, cuts DOE spending for nuclear medicine science by $23 million. The new budget will eliminate funding for more than 80 projects in molecular medicine conducted mainly at the DOE's national laboratories at Brookhaven, NY, Los Alamos, NM, and Pine Ridge, TN, according to the Society of Nuclear Medicine.
Restoration of the cuts is the SNM's top legislative priority. The cuts threaten to break a historic link between the advancement of nuclear medicine technologies and DOE-funded programs that originated with the former Atomic Energy Commission's Atoms for Peace program in 1954. DOE-supported research helped fund development of SPECT and PET cameras, the molybdenum-99m/technetium-99m generator, F-18 fluorodeoxyglucose for medical imaging applications, and other key discoveries.
The budget cuts will pull the plug on discoveries that could have translated into better disease management for millions of patients fighting oncologic, neurologic, and cardiovascular diseases each year, according to SNM president Dr. Peter Conti. Nuclear medicine researchers fear the loss of the DOE programs will slow research leading to new radioisotopes for nuclear medicine, production of rare radioisotopes for cancer therapy, and training of new nuclear chemists to lead future research efforts.
Some National Cancer Institute officials have suggested that many DOE-funded projects could qualify for NCI grants. But nuclear medicine researchers are concerned about the loss of DOE infrastructure, such as cyclotrons at Brookhaven and Los Alamos, and the dismantling of research staffs devoted to nuclear medicine research.
"The outcome is clear. Basic nuclear and molecular imaging research will decline beginning in 2006, and our professional community may have to fight a hard battle to maintain other federal research funding in 2007," Conti said.
For more information from the Diagnostic Imaging archives:
Advocates opposed planned cuts in clinical research
Funding cuts imperil nuclear medicine's innovative tradition
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
